Igor Shamovsky
11Patents
4h-index
17Co-inventors
57Inventor score
Filing activity: Apr 23, 1997 → May 10, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6291247A | Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity | Emerging Cross-Sectional Technologies | 61 | Expired |
| US6492380B1 | Method of inhibiting neurotrophin-receptor binding | Human Necessities | 32 | Expired |
| US6417159B1 | Method of enhancing effect of a neurotrophin with analogues of p75NTR367-379. | Human Necessities | 21 | Expired |
| US6029114A | Molecular modelling of neurotrophin-receptor binding | Physics | 20 | Expired |
| US7148352B2 | Method of inhibiting neurotrophin-receptor binding | Chemistry; Metallurgy | 4 | Expired |
| US6468990B1 | Method of inhibiting binding of nerve growth factor to p75 NTR receptor | Chemistry; Metallurgy | 4 | Expired |
| US7655664B2 | Hydantoin derivatives as metalloproteinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US7700604B2 | Hydantoin derivatives as metalloproteinase inhibitors | Chemistry; Metallurgy | 3 | Expired |
| US10954211B2 | Chemical compounds | Human Necessities | 0 | Active |
| US9873678B2 | Chemical compounds | Human Necessities | 0 | Active |
| US10336725B2 | Chemical compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.